Kroll Bond Rating Agency Maintains Dime’s Outlook at “Stable” and Affirms Ratings
HAUPPAUGE, N.Y., June 17, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (the “Company” or “Dime”) (NASDAQ: DCOM), the parent […]
Plains All American Announces Pricing of Public Offering of $650 Million of Senior Notes
HOUSTON, June 17, 2024 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (NYSE: PAA) today announced that it and PAA […]
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and […]
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
MIAMI, FL, June 17, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on […]
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on […]
Actelis Partners with Carahsoft, a Major US-based IT Software and Services Company, to Expand Access for Its Cyber-Secure, Immediate Deployment IoT Connectivity to US Government Agencies
Actelis Solutions Now Available Through Carahsoft’s Public Sector Resellers and Government Contract Vehicles FREMONT, Calif., June 17, 2024 (GLOBE NEWSWIRE) — […]
Spectral AI to Participate in the Northland Capital Markets Virtual Growth Conference
DALLAS, June 17, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence […]
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field […]
Earlyworks Co., Ltd. Regains Compliance with Nasdaq Minimum Bid Price Requirement
TOKYO, June 17, 2024 (GLOBE NEWSWIRE) — Earlyworks Co., Ltd. (NASDAQ: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating […]
Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel
TAMPA, Fla., June 17, 2024 (GLOBE NEWSWIRE) — Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical […]
